A homozygous genetic variant of mitochondrial uncoupling protein 4 exerts protection against the occurrence of multiple sclerosis

NeuroMolecular Medicine

Volumn 11, Issue 2, 2009, Pages 101-105

  Szolnoki, Zoltan ^a   Kondacs, Andras ^a   Mandi, Yvette ^b   Bodor, Anita ^c   Somogyvari, Ferenc ^b  

^a Pandy Kalman County Hospital   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c Rethy Pal Hospital   (Hungary)

Author keywords

Genetic variant; Mitochondria; Mitochondrial membrane potential; Mitochondrial uncoupling protein; Multiple sclerosis

Indexed keywords

GENOMIC DNA; MATRIX METALLOPROTEINASE; MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 4; CARRIER PROTEIN; SLC25A27 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN PROTECTION; CELL METABOLISM; CONTROLLED STUDY; DEMYELINATION; ENERGY METABOLISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WHITE MATTER; AGED; GENETICS; METABOLISM; MIDDLE AGED; MITOCHONDRION; PHYSIOLOGY;

ADULT; AGED; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MITOCHONDRIA; MULTIPLE SCLEROSIS;

EID: 70349773947     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8071-4     Document Type: Article

References (21)

1. K Bencsik C Rajda J Fuvesi P Klivenyi T Jardanhazy M Torok L Vecsei 2001 The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrad County, Hungary European Neurology 46 206 209 11721128 10.1159/000050806 1:STN:280:DC%2BD3MnnsFSjug%3D%3D (Pubitemid 33135795)
2. E Karg P Klivenyi K Bencsik S Turi L Vecsei 2003 Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatment European Neurology 50 215 219 14634265 10.1159/000073862 1:CAS:528:DC%2BD3sXpt1WgsLs%3D (Pubitemid 37499936)
3. S Komoly LD Hudson HD Webster CA Bondy 1992 Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination Proceedings of the National Academy of Sciences of the United States of America 89 1894 1898 1371885 10.1073/pnas.89.5.1894 1:CAS:528:DyaK38Xhs1Oju7k%3D
4. JF Kurtzke 1993 Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDDS) Neurology 33 1442 1452
5. D Liu SL Chan NC de Souza-Pinto JR Slevin RP Wersto M Zhan K Mustafa R de Cabo MP Mattson 2006 Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress Neuromolecular Medicine 8 389 414 16775390 10.1385/NMM:8:3:389 1:CAS:528:DC%2BD28Xls1ShsLs%3D (Pubitemid 43918160)
6. MP Mattson D Liu 2003 Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death Biochemical and Biophysical Research Communications 9 539 549 10.1016/S0006-291X(03)00627-2 (Pubitemid 36506527)
7. WI McDonald A Compston G Edan D Goodkin HP Hartung FD Lublin HF McFarland DW Paty CH Polman SC Reingold M Sandberg-Wollheim W Sibley A Thompson S van den Noort BY Weinshenker JS Wolinsky 2001 Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis Annals of Neurology 50 121 127 11456302 10.1002/ana.1032 1:STN:280:DC%2BD38%2FitFOhug%3D%3D (Pubitemid 32591472)
8. DH Miller F Barkof I Berry L Kappos S Scotti AJ Thompson 1991 Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted action guidelines Journal of Neurology, Neurosurgery and Psychiatry 54 683 688 10.1136/jnnp.54.8.683 1:STN:280:DyaK38%2FksVGksw%3D%3D
9. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Research 16 1215 1218 3344216 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D
10. D Otaegui A Saenz J Ruiz-Martinez J Olaskoaga A López de Munain 2007 UCP2 and mitochondrial haplogroups as a multiple sclerosis risk factor Multiple Sclerosis 13 4 454 458 17463068 1:CAS:528:DC%2BD2sXmvVOiu7g%3D
11. CM Poser DW Paty L Scheimberg WI McDonald FA Davis GC Ebers KP Johnson WA Sibley DH Silberberg WW Tourtellotte 1983 New diagnostic criteria for multiple sclerosis: Guidelines for research protocols Annals of Neurology 13 227 231 6847134 10.1002/ana.410130302 1:STN:280:DyaL3s3gt1OgtQ%3D%3D (Pubitemid 13158528)
12. Z Szolnoki 2007 Pathomechanism of leukoaraiosis: Molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis) Neuromolecular Medicine 9 21 33 17114822 10.1385/NMM:9:1:21 1:CAS:528: DC%2BD2sXot1Oms78%3D (Pubitemid 44772273)
13. Z Szolnoki A Kondacs Y Mandi F Somogyvari 2007 A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: Gene-environmental interactions behind vascular white matter demyelinization Journal of Molecular Neuroscience 33 173 179 17917076 10.1007/s12031-007-0062-z 1:CAS:528:DC%2BD2sXhtFyit7vN (Pubitemid 47574940)
14. Z Szolnoki A Kondacs Y Mandi F Somogyvari 2007 A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: The janus face of the kinesin light-chain 1 56836CC genetic variant Neuromolecular Medicine 9 335 339 17999208 10.1007/s12017-007-8014-x 1:CAS:528:DC%2BD2sXhsVWitrbJ (Pubitemid 350242637)
15. AJ Thompson X Montalban F Barkhof, et al. 2000 Diagnostic criteria for primary progressive multiple sclerosis: A position paper Annals of Neurology 47 831 835 10852554 10.1002/1531-8249(200006)47:6<831::AID-ANA21>3.0.CO;2-H 1:STN:280:DC%2BD3czgvFeqtg%3D%3D (Pubitemid 30390209)
16. M Tintoré A Rovira MJ Martinez, et al. 2000 Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion clinically definite multiple sclerosis American Journal of Neuroradiology 21 702 706 10782781
17. S Vogler R Goedde B Miterski R Gold A Kroner D Koczan UK Zettl P Rieckmann JT Epplen SM Ibrahim 2005 Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis Journal of Molecular Medicine 83 10 806 811 16021520 10.1007/s00109-005-0661-5 1:CAS:528: DC%2BD2MXhtVOhur3J (Pubitemid 41407864)
18. S Vogler J Pahnke S Rousset D Ricquier H Moch B Miroux SM Ibrahim 2006 Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis American Journal of Pathology 168 5 1570 1575 16651623 10.2353/ajpath.2006.051069 1:CAS:528:DC%2BD28XkvF2nt7g%3D
19. K Yasuno S Ando S Misumi S Makino JK Kulski T Muratake N Kaneko H Amagane T Someya H Inoko H Suga K Kanemoto G Tamiya 2007 Synergistic association of mitochondrial uncoupling protein (UCP) genes with schizophrenia American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 144B 2 250 253 10.1002/ajmg.b.30443 (Pubitemid 46606652)
20. Yoon, Y., Park, B. L., Cha, M. H., Kim, K. S., Cheong, H. S., Choi, Y. H., et al. (2007). Effects of genetic polymorphisms of UCP2 and UCP3 on very low calorie diet-induced body fat reduction in Korean female subjects. Biochemical and Biophysical Research Communications, 359(3), 451-456.
21. Yu, X., Wieczorek, S., Franke, A., Yin, H., Pierer, M., Sina, C., et al. (2009). Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. doi: 10.1038/gene.2009.29.